InvestorsHub Logo
Sticky
sunspotter

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
TheHound Free
03/18/24 10:21 PM
profile icon
dougwur Free
03/18/24 1:29 PM
Bearish
Bearish
profile icon
PJ007 Free
03/18/24 1:18 PM
profile icon
AngusPorter Free
03/18/24 12:57 PM
profile icon
PJ007 Free
03/18/24 12:54 PM
profile icon
AngusPorter Free
03/18/24 12:09 PM
profile icon
PJ007 Free
03/18/24 9:48 AM
profile icon
MackG PremiumMember
03/18/24 9:28 AM
profile icon
loanranger PremiumMember
03/18/24 9:26 AM
profile icon
loanranger PremiumMember
03/17/24 11:35 AM
profile icon
snayeman Free
03/17/24 11:19 AM
profile icon
steelyeye Free
03/17/24 12:13 AM
profile icon
PJ007 Free
03/16/24 4:13 PM
profile icon
JTORENCE Free
03/16/24 12:41 PM
profile icon
TheHound Free
03/16/24 12:17 PM
profile icon
StockJumper25 PremiumMember
03/16/24 11:23 AM
profile icon
backtoreality Free
03/16/24 11:11 AM
profile icon
steelyeye Free
03/15/24 6:08 PM
profile icon
steelyeye Free
03/15/24 6:02 PM
profile icon
sunspotter Free
03/14/24 4:42 PM
Bearish
Bearish
profile icon
MackG PremiumMember
03/14/24 4:13 PM
profile icon
Luckytouch Free
03/13/24 10:36 PM
profile icon
steelyeye Free
03/13/24 8:34 PM
profile icon
steelyeye Free
03/13/24 8:04 PM
profile icon
williamssc Free
03/13/24 2:45 PM
profile icon
Luckytouch Free
03/13/24 2:34 PM
profile icon
PJ007 Free
03/13/24 1:36 PM
profile icon
loanranger PremiumMember
03/13/24 1:18 PM
profile icon
MackG PremiumMember
03/13/24 12:32 PM
profile icon
PJ007 Free
03/13/24 12:25 PM
profile icon
cantwate Free
03/13/24 12:13 PM
profile icon
zandant Grandfathered
03/13/24 11:11 AM
profile icon
loanranger PremiumMember
03/13/24 10:20 AM
profile icon
MackG PremiumMember
03/12/24 4:51 PM
profile icon
loanranger PremiumMember
03/12/24 1:32 PM
profile icon
MackG PremiumMember
03/12/24 11:30 AM

Innovation Pharmaceuticals Inc (IPIX) RSS Feed

Followers
981
Posters
Posts (Today)
0
Posts (Total)
402069
Created
05/10/08
Type
Free
Moderators zandant Minnesinger sunspotter snayeman loanranger frenchbroad

Innovation Pharmaceuticals Inc. (IPIX) 

$IPIX NEWShttp://ipharminc.com/press-release

SEC Filings  https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany

From the most recent 10-K:

There are doubts about our ability to continue as a going concern.
We have generated revenue of $0 and $18,000 for the fiscal years ended June 30, 2023 and 2022, respectively and have an accumulated deficit of $125.3 million through June 30, 2023. These factors raise substantial doubt about our ability to continue as a going concern.
We need to raise substantial additional capital in the future to fund our operations and we may be unable to raise such funds when needed and on acceptable terms, which could prevent us from fully implementing our business, operating and development plans.
We currently have an approximate $1.0 million cash balance as of the date of this filing, but that is insufficient to complete the development and commercialization of any of our proposed products. We expect to incur costs of approximately $1.8 million in the upcoming fiscal year ending June 30, 2024 to operate our business in accordance with our business plans and budgets.
We have limited experience in drug and formulation development, the conduct of clinical trials, and may not be able to successfully develop any drugs.
Development of pharmaceutical products is a risky and time-consuming process subject to a number of factors, many of which are outside of our control. We are subject to regulatory authority permissions and approvals, most importantly the FDA. Our drug candidate(s)/indications are at early and mid-stages of development. Consequently, we can provide no assurance of the successful and timely development of new drugs, and the failure to do so could cause us to cease operations.


We may elect to deregister our common stock under the Exchange Act and suspend our reporting obligations. Such deregistration and suspension would result in less disclosure about us and may negatively affect the liquidity and trading prices of our common stock.

 

 
http://www.ipharminc.com/
 
About Innovation Pharmaceuticals Inc.: 
 

Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pharmaceuticals Inc. (formerly Cellceutix Corporation) is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.


Through ongoing research and drug development efforts, Innovation is focused on improving the clinical care of patients, as well as growing shareholder value. Our team consists of a diverse and accomplished group of professionals working together toward achieving this common goal. 

IPIX CEO - "The Company historically devoted most of its efforts and resources on business development, regulatory matters, and clinical trials. Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully." "In general, we expect to concentrate on product development and engage in a limited way in product discovery, avoiding the significant investment of time and financial resources that is generally required for a promising compound to be identified and brought into clinical trials." Source - https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223003414/ipix_10q.htm
 

More information is available at http://www.ipharminc.com.

Management:  http://www.ipharminc.com/senior-management/

Scientific Advisors:  http://www.ipharminc.com/scientific-advisors/

Clinical Trials:  https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%2C+Inc.%22++&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Trials under previous name:   https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps

 
Product Pipeline:  http://www.ipharminc.com/therapeutic-areas/

 


Recent News and Press Releases: 
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/

 
SEC Filings (CIK:0001355250): 
https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com

 
Share Structure:  See SEC filing link above for current share structure


Investor Relations: 
http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1


Chart:   https://stockcharts.com/h-sc/ui?s=IPIX

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

Top Posts With Reactions
(Last 30 Days)
profile-icon
MackG 03/13/24 12:32 PM
👍️
💲
😂
12
profile-icon
PJ007 03/07/24 9:35 AM
👍️
💲
🤑
12
profile-icon
cantwate 02/24/24 11:55 AM
👍️
💲
12
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post